Anomalies of the TGF-β postreceptor signaling pathway in ovarian cancer cell lines

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 729-733

  Hu, Wei ^a,c   Wu, Weiguo ^c   Nash, Micheal A ^b   Freedman, Ralph S ^b   Kavanagh, John J ^a   Verschraegen, Claire F ^a  

^a Sect Gynecologic Med Therapeut   (United States)

^b Gynecologic Oncology of Houston   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

C myc; CDC25; Ovarian neoplasm; Signaling pathway; Smad4; Transforming growth factor receptor II

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG RESISTANCE; GENE OVEREXPRESSION; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CDC25 PHOSPHATASE; CELL CYCLE; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0034009725     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fox H: Origins of Ovarian Cancer. In: Kavanagh JJ, Singletary S, Pecorelli S, DiPetrillo A, Einhorn N (eds): Cancer in Women. Blackwell Scientific Publications. Cambridge, MA 1998, pp. 405-414.
2. Berchuck A. Rodriguez G, Olt G, Whitaker R, Boente MP, Arrick BA, Clarke -Pearson DL, Bast RC: Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am J Obstet Gynecol 166: 676-684, 1992.
3. Fynan TM, Reiss M: Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit Rev Oncol 4: 493-540, 1993.
4. Iavarone A, Massague J: Repression of the CDK activator CDC25 and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387: 417-421, 1997.
5. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387: 422-426, 1997.
6. watl induction are important early events. Cell Growth & Differ 7: 1291-1304, 1996.
7. De Winter JP, Roelen BA, ten Dijke P, van der Burg B, van den Eijnde-van Raaij AJ: DPC4 (SMAD4) mediates transforming growth facto-β1 induced growth inhibition and transcriptional response in breast tumor cells. Oncogene 14(16): 1891-9, 1997.
8. Wei O, Xu X, Cheng L, Legerski RJ, Ali-Osman F: Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR. Cancer Res 55: 5025-5029, 1995.
9. Wang D, Song H, Evans JA, Lang JC, Schuller DE, Weghots CM: Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas ot the head and neck. Carcinogenesis 18(11): 2285-90, 1997.
10. Wu WG, Fan YH, Kemp BL, Walsh G, Mao L: Overexpression of CDC25A and CDC25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of C-myc. Cancer Res 58(18): 4082-5, 1998.
11. Verschraegen C F, Hu W, Mendoza J, Du Y, Kudelka AP, Freedman RF, Kavanagh JJ, and Giovanella B: Establishment and charaeterization of mullerian cell lines derived from primary ovarian cancer. Proc. Am. Asso. Cancer Res A3291: 499, 1999.
12. Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomot T, and Weghorst CM: Mutational analysis of the transforming growth factor b receptor type II gene in human ovarian carcinoma Cancer Res 58: 4227-4232, 1998.
13. Galaktionov K, Lee AK, Fekstein J, Draetta G, Meckler J, Loda M, Beach D: CDC25 phosphatases as potential human oncogenes. Science 269: 1575-7, 1995.
14. Draetta G, and Eckstein J: CDC 25 protein phosphatases in cell proliferation. Biochem Biophys Acta 1332: M53-63, 1997.
15. Lemaitre JM, Buckle R, Mechali M: C-myc in the control of cell proliferation and embryonic development. Adv Cancer Res 70: 95-144, 1996.
16. Nash MA, Ferrandina G, Gordinier M, Loercher A, and Freedman RS: The role of cytokine in both normal and malignant ovary. Endocrine-Relat Cancer 6: 93-107, 1999.
17. Villanueva A, Garcia C, Belen Paules A, Vicente M, Megias M, Reyes G, De Villalonga P, Agell N, Pluis E, Bachs O, Capella G: Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene 17: 1969-78, 1998.
18. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy G M, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA, Jr Meltzer PS, Hahn SA, Kern SE: DPC4 gene in various tumor types. Cancer Res 56: 2527-30, 1996.